Alibaba Health Information Stock Performance
| ALBHF Stock | USD 0.82 0.04 4.65% |
Alibaba Health has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.45, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Alibaba Health are expected to decrease at a much lower rate. During the bear market, Alibaba Health is likely to outperform the market. Alibaba Health Infor right now shows a risk of 3.1%. Please confirm Alibaba Health Infor value at risk, kurtosis, and the relationship between the sortino ratio and semi variance , to decide if Alibaba Health Infor will be following its price patterns.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Alibaba Health Information are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical indicators, Alibaba Health may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
| Begin Period Cash Flow | 7.3 B | |
| Total Cashflows From Investing Activities | 1.9 B |
Alibaba |
Alibaba Health Relative Risk vs. Return Landscape
If you would invest 78.00 in Alibaba Health Information on November 6, 2025 and sell it today you would earn a total of 4.00 from holding Alibaba Health Information or generate 5.13% return on investment over 90 days. Alibaba Health Information is currently producing 0.131% returns and takes up 3.0965% volatility of returns over 90 trading days. Put another way, 27% of traded pink sheets are less volatile than Alibaba, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Alibaba Health Target Price Odds to finish over Current Price
The tendency of Alibaba Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.82 | 90 days | 0.82 | about 16.38 |
Based on a normal probability distribution, the odds of Alibaba Health to move above the current price in 90 days from now is about 16.38 (This Alibaba Health Information probability density function shows the probability of Alibaba Pink Sheet to fall within a particular range of prices over 90 days) .
Alibaba Health Price Density |
| Price |
Predictive Modules for Alibaba Health
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Alibaba Health Infor. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Alibaba Health Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Alibaba Health is not an exception. The market had few large corrections towards the Alibaba Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Alibaba Health Information, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Alibaba Health within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.07 | |
β | Beta against Dow Jones | -0.45 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | 0 |
Alibaba Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Alibaba Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Alibaba Health Infor can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Alibaba Health Infor has some characteristics of a very speculative penny stock | |
| Alibaba Health Infor had very high historical volatility over the last 90 days | |
| The company reported the revenue of 20.58 B. Net Loss for the year was (265.56 M) with profit before overhead, payroll, taxes, and interest of 4.11 B. | |
| About 65.0% of the company shares are held by company insiders |
Alibaba Health Fundamentals Growth
Alibaba Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Alibaba Health, and Alibaba Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Alibaba Pink Sheet performance.
| Return On Equity | 0.0088 | |||
| Return On Asset | -0.0168 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 14.83 B | |||
| Shares Outstanding | 13.52 B | |||
| Price To Earning | 232.77 X | |||
| Price To Book | 7.69 X | |||
| Price To Sales | 0.61 X | |||
| Revenue | 20.58 B | |||
| EBITDA | (248.7 M) | |||
| Cash And Equivalents | 10.55 B | |||
| Cash Per Share | 0.78 X | |||
| Total Debt | 135.41 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 1.11 X | |||
| Cash Flow From Operations | 424.36 M | |||
| Total Asset | 19.2 B | |||
About Alibaba Health Performance
By analyzing Alibaba Health's fundamental ratios, stakeholders can gain valuable insights into Alibaba Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Alibaba Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Alibaba Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. Alibaba Health Information Technology Limited is based in Causeway Bay, Hong Kong. Alibaba Health operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 1849 people.Things to note about Alibaba Health Infor performance evaluation
Checking the ongoing alerts about Alibaba Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Alibaba Health Infor help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Alibaba Health Infor has some characteristics of a very speculative penny stock | |
| Alibaba Health Infor had very high historical volatility over the last 90 days | |
| The company reported the revenue of 20.58 B. Net Loss for the year was (265.56 M) with profit before overhead, payroll, taxes, and interest of 4.11 B. | |
| About 65.0% of the company shares are held by company insiders |
- Analyzing Alibaba Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Alibaba Health's stock is overvalued or undervalued compared to its peers.
- Examining Alibaba Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Alibaba Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Alibaba Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Alibaba Health's pink sheet. These opinions can provide insight into Alibaba Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Alibaba Pink Sheet analysis
When running Alibaba Health's price analysis, check to measure Alibaba Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alibaba Health is operating at the current time. Most of Alibaba Health's value examination focuses on studying past and present price action to predict the probability of Alibaba Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alibaba Health's price. Additionally, you may evaluate how the addition of Alibaba Health to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |